Healthcare Technology
What Is CRISPR? Gene Editing Technology and Its Biotech Investment Implications
In 2020, Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in Chemistry for developing CRISPR-Cas9 — a gene editing technology that has been described as one of the most significant scientific advances of the twenty-first century. For biotech investors, CRISPR is not just a scientific concept; it is a foundational platform technology that…
